- You are here: Home
- Resources
- Explore & Learn
- Histology
- Instructions for Tumour Tissue Collection, Storage and Dissociation
Support
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Instructions for Tumour Tissue Collection, Storage and Dissociation
Tumor tissue makes for highly valuable sample material. Samples are treated with utter care to prevent, for instance, sample degeneration or unwanted cell activation. Effective tumor tissue collection, storage, and dissociation are critical components in cancer research and clinical diagnostics. High-quality samples enable reliable data for understanding tumor biology, testing therapies, and developing personalized medicine.
Preparation for Tumor Tissue Collection
Before collection, meticulous preparation is vital. Establishing a sterile environment minimizes contamination risks and preserves sample viability. Comprehensive considerations should include the following:
- Sample selection. Researchers should select tumor specimens that are representative of the disease state to ensure the relevance of experimental results.
- Sterile equipment. Use sterile collection containers, forceps, and scalpels to minimize the risk of contamination.
- Preservation solutions. Prepare cold transport media or preservation solutions to maintain tissue viability during transport.
Tumor Tissue Collection Techniques
The choice of collection technique heavily influences the quality and applicability of the tissue samples. Surgical resection and biopsy techniques are utilized. In cases where tumors are surgically excised, the collection must occur promptly. Biopsies, either needle or excisional, provide valuable tissue with minimal invasiveness.
- Minimize the time between excision and stabilization in preservation media to limit ischemic changes.
- Use clean margins to ensure that the collected tissue is representative of the tumor's histology.
- Core needle biopsy allows for deeper penetration and larger samples, which can be especially beneficial for tumors that are not easily accessible.
- Fine needle aspiration (FNA) is less invasive, making it suitable for superficial tumors. While it yields smaller samples, proper technique can capture sufficient cellular material for diagnostic purposes.
Immediate Post-Collection Handling
Proper handling immediately after collection is crucial to maintaining sample integrity. Key considerations include:
- Transport conditions. Tumor tissues should be transported in an appropriate medium, such as saline or specialized preservation solutions, and kept at physiological temperatures to reduce metabolic activity.
- Time management. Aim to process or refrigerate the samples within 30 minutes of collection to minimize decomposition and enzymatic degradation.
Tumor Tissue Storage Techniques
Before freezing, divide tissue into 10-30 mg portions for most tissues (e.g. spleen, liver, kidney, brain), or 60 mg portions for tissues with low nuclei content relative to tissue mass. Tissues with higher nuclei content relative to tissue mass: spleen, brain, liver, lung, kidney, thyroid, colon, bladder, ovary, testes, colon, prostate, and most breast tissue. Tissues with lower nuclei content relative to tissue mass: some fatty tissues, including fatty breast tissue, and most skeletal muscle.
Short-term storage
For interim storage, maintaining the tissue at 4°C is advisable. This approach is suitable for samples that will be processed within a few hours. However, samples should not exceed 24 hours at these temperatures to prevent degradation.
Long-term storage
For extended preservation, cryopreservation is the preferred strategy. Important steps include:
- Flash freezing. This process rapidly lowers the tissue temperature to prevent ice crystal formation, which can damage cellular structures. Techniques involve immersing samples in liquid nitrogen or using specialized cryopreservation containers.
- Storage in liquid nitrogen. For optimal preservation, samples should be stored in liquid nitrogen tanks at temperatures below -150°C, effectively halting all biological activity.
Tumor Tissue Dissociation Techniques
Enzymatic dissociation
Utilizing enzymes such as collagenase or dispase can facilitate the breakdown of extracellular matrices, allowing for easier cell retrieval. This technique is preferred for its ability to maintain cell viability post-dissociation.
Mechanical dissociation
For larger fragments or more fibrous tissues, mechanical dissociation methods may be employed.
- Homogenization. This technique uses mechanical devices to shear tissue apart, suitable for obtaining large quantities of cells from solid tumors.
- Manually slicing. For certain applications, manually slicing and physically breaking up the tissue may yield adequate results without the risks associated with enzymatic treatments.
Creative Bioarray Relevant Recommendations
Cat. No. | Product Name |
AGTMA002 | Human adrenal tumor tissue array |
BCTMA020 | Human bone and cartilage tumor tissue array |
INTMA001 | Human large intestine tumor tissue array |
INTMA007 | Human small intestine tumor tissue array |
INTMA011 | Human small intestine tumor tissue array |
INTMA013 | Human small intestine tumor tissue array |
INTMA014 | Human large intestine tumor tissue array |
LITMA161 | Human liver late-stage tumor tissue microarray |
For research use only. Not for any other purpose.